Progesterone Receptor, AbBy Fluor-594 Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bsm-60804r-bf594 |
| Product Name | Progesterone Receptor, AbBy Fluor-594 Conjugated |
| Applications |
WB
FCM
IF(IHC-P)
IF(ICC)
|
| Reactivity | Human |
| Specifications | |
| Conjugation | AbBy Fluor-594 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human progesterone receptor |
| Clonality | Monoclonal |
| Clone # | No |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 5241 |
| Swiss Prot | P06401 |
| Subcellular location | Cytoplasm, Nucleus |
| Synonyms | NR3C3; Nuclear receptor subfamily 3 group C member 3; PGR; PR; PRA; PRB; Progesterone receptor; Progestin receptor form A; Progestin receptor form B; PRGR_HUMAN; Progestin receptor form A; Progestin receptor form B. |
| Background | Estrogen and progesterone receptor are members of a family of transcription factors that are regulated by the binding of their cognate ligands. The interaction of hormone-bound estrogen receptors with estrogen responsive elements(EREs) alters transcription of ERE-containing genes. The carboxy terminal region of the estrgen receptor contains the ligand binding domain, the amino terminus serves as the transactivation domain, and the DNA binding domain is centrally located. Two forms of estrogen receptor have been identified, ER alpha and ER beta. ER alpha and ER beta have been shown to be differentially activated by various ligands. The biological response to progesterone is mediated by two distinct forms of the human progesterone receptor (hPR-Aand hPR-B), which arise from alternative splicing. In most cells, hPR-B functions as a transcriptional activator of progesterone-responsive gene, whereas hPR-A function as a transcriptional inhibitor of all steroid hormone receptors. |
| Application Dilution | |
| WB | 1:500-2000 |
| FCM | FCM1ug/Test |
| IF(IHC-P) | IFIHC-P1:100-500 |
| IF(ICC) | IFICC1:50-200 |
Frequently asked questions
Which applications is Progesterone Receptor, AbBy Fluor-594 Conjugated (bsm-60804R-BF594) validated for, and at what dilution?
bsm-60804R-BF594 is validated for WB(WB) (1:500-2000); FCM(FCM) (1ug/Test); IF(IHC-P)(IF(IHC-P)) (1:100-500); IF(ICC)(IF(ICC)) (1:50-200). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does Progesterone Receptor, AbBy Fluor-594 Conjugated (bsm-60804R-BF594) react with?
Tested reactivity: Human.
How should bsm-60804R-BF594 be stored?
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise Progesterone Receptor, AbBy Fluor-594 Conjugated (bsm-60804R-BF594)?
KLH conjugated synthetic peptide derived from human progesterone receptor
What are the excitation and emission wavelengths of the AbBy Fluor-594 conjugate (bsm-60804R-BF594)?
AbBy Fluor-594 on bsm-60804R-BF594: excitation / emission 590nm/617nm.